Paget’s Disease of the Male Breast: A Diagnostic Challenge
DOI:
https://doi.org/10.2340/actadv.v105.42233Keywords:
Paget’s disease, Mammary Paget’s disease, Paget’s disease of the breast, Male breast cancerDownloads
References
Caliskan M, Gatti G, Sosnovskikh I, Rotmensz N, Botteri E, Musmeci S, et al. Paget's disease of the breast: the experience of the European institute of oncology and review of the literature. Breast Cancer Res Treat 2008; 112: 513-521.
https://doi.org/10.1007/s10549-007-9880-5 DOI: https://doi.org/10.1007/s10549-007-9880-5
Markarian S, Holmes DR. Mammary Paget's disease: an update. Cancers 2022; 14: 2422.
https://doi.org/10.3390/cancers14102422 DOI: https://doi.org/10.3390/cancers14102422
Filho LLL, Lopes IMRS, Lopes LRS, Enokihara MMSS, Michalany AO, Matsunaga N. Mammary and extramammary Paget's disease. An Bras Dermatol 2015; 90: 225-231.
https://doi.org/10.1590/abd1806-4841.20153189 DOI: https://doi.org/10.1590/abd1806-4841.20153189
Adams SJ, Kanthan R. Paget's disease of the male breast in the 21st century: a systematic review. Breast 2016; 29: 14-23.
https://doi.org/10.1016/j.breast.2016.06.015 DOI: https://doi.org/10.1016/j.breast.2016.06.015
Joshi MG, Lee AKC, Loda M, Camus MG, Pedersen C, Heatley GJ, et al. Male breast carcinoma: an evaluation of prognostic factors contributing to a poorer outcome. Cancer 1996; 77: 490-498. DOI: https://doi.org/10.1002/(SICI)1097-0142(19960201)77:3<490::AID-CNCR10>3.0.CO;2-#
https://doi.org/10.1002/(SICI)1097-0142(19960201)77:3<490::AID-CNCR10>3.0.CO;2-#
Janku F, Yap TA, Meric-Bernstam F. Targeting the PI3K pathway in cancer: are we making headway? Nat Rev Clin Oncol 2018; 15: 273-291.
https://doi.org/10.1038/nrclinonc.2018.28 DOI: https://doi.org/10.1038/nrclinonc.2018.28
Song Y, Guerrero-Juarez CF, Chen Z, Tang Y, Ma X, Lv C, et al. The Msi1-mTOR pathway drives the pathogenesis of mammary and extramammary Paget's disease. Cell Res 2020; 30: 854-872.
https://doi.org/10.1038/s41422-020-0334-5 DOI: https://doi.org/10.1038/s41422-020-0334-5
Arafah M, Arain SA, Raddaoui EMS, Tulba A, Alkhawaja FH, Al Shedoukhy A. Molecular subtyping of mammary Paget's disease using immunohistochemistry. Saudi Med J 2019; 40: 440-446.
https://doi.org/10.15537/smj.2019.5.23967 DOI: https://doi.org/10.15537/smj.2019.5.23967
Sek P, Zawrocki A, Biernat W, Piekarski JH. HER2 molecular subtype is a dominant subtype of mammary Paget's cells. An immunohistochemical study. Histopathology 2010; 57: 564-571.
https://doi.org/10.1111/j.1365-2559.2010.03665.x DOI: https://doi.org/10.1111/j.1365-2559.2010.03665.x
Published
How to Cite
License
Copyright (c) 2025 Eléna Prospero, Marie Jouandet, Jean-Marc Chevallier, Anne Dompmartin, Jean-Matthieu L'Orphelin
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
